LB Pharmaceuticals Inc (LBRX) stock
LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.06−0.24 (-0.60%)
Close on Nov 18, 2026Market cap $1.29BP/E –Yield –
LB Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
LB Pharmaceuticals's cash was $324.90M at Jun 30, 2026. For fiscal 2025 it was $295.20M, up 1060.2% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $295.20M | +1060.2% |
| FY2024 | Dec 31, 2024 | $25.45M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $324.90M | +1176.9% |
| Q1 FY2026 | Mar 31, 2026 | $364.85M | – |
| Q4 FY2025 | Dec 31, 2025 | $295.20M | – |
| Q3 FY2025 | Sep 30, 2025 | $314.50M | – |
| Q4 FY2024 | Dec 31, 2024 | $25.45M | – |
See a number that looks wrong?